Loading clinical trials...
Loading clinical trials...
Detection of RNA Binding Protein Pumilio1 (PUM1) Expression in Patients With Sickle Cell Anemia and β-thalassemia Intermedia
Conditions
Interventions
RNA Binding Protein Pumilio1 (PUM1) Expression by reverse transcriptase quantatative PCR
Start Date
August 1, 2023
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2027
Last Updated
May 31, 2023
Lead Sponsor
Assiut University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions